Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene

Neurobiology of Aging

Volumn 33, Issue 2, 2012, Pages 393-403

  Pfeffer, Martina ^a   Plenzig, Stefanie ^a   Gispert, Suzana ^a   Wada, Keiji ^b   Korf, Horst Werner ^a   von Gall, Charlotte ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Alzheimer's disease; Circadian rhythms; Clock genes; Gad; Hypocretin; Locomotor activity; Melanopsin; Neurodegenerative disorders; Orexin; Parkinson's disease; UCH L1

Indexed keywords

MELANOPSIN; OREXIN A; PROTEIN BMAL1; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; BRIGHTNESS; CELL LOSS; CONTROLLED STUDY; DARKNESS; DEGENERATIVE DISEASE; EXON; GENE; GENE DELETION; GENE FUNCTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL HYPOTHALAMUS; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; PHOTOPERIODICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA; RETINA GANGLION CELL; SLEEP DISORDER; SLEEP WAKING CYCLE; UCH L1 GENE;

ANIMALS; BIOLOGICAL CLOCKS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; GENE DELETION; HYPOTHALAMUS; LIGHT SIGNAL TRANSDUCTION; LOCOMOTION; MALE; MICE; MICE, KNOCKOUT; NEURONS; RETINA; SLEEP DISORDERS; UBIQUITIN THIOLESTERASE;

EID: 82755177619     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.02.019     Document Type: Article

References (41)

1. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., Curb J.D., Petrovitch H. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005, 65:1442-1446.
2. Benca R.M., Gilliland M.A., Obermeyer W.H. Effects of lighting conditions on sleep and wakefulness in albino Lewis and pigmented Brown Norway rats. Sleep 1998, 21:451-461.
3. Berson D.M., Dunn F.A., Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295:1070-1073.
4. Borbely A.A. Sleep and motor activity of the rat during ultra-short light-dark cycles. Brain Res 1976, 114:305-317.
5. Braak H., Del Tredici K., Rub U., de Vos R.A.I., Steur E.N.H.J., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
6. Campbell S.S., Kripke D.F., Gillin J.C., Hrubovcak J.C. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol. Behav 1988, 42:141-144.
7. Chaudhuri K.R. Nocturnal symptom complex in PD and its management. Neurology 2003, 61:S17-S23.
8. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem 2004, 279:13256-13264.
9. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med 2007, 8:S27-S34.
10. Dhawan V., Healy D.G., Pal S., Chaudhuri K.R. Sleep-related problems of Parkinson's disease. Age Ageing 2006, 35:220-228.
11. Dong X., Yagita K., Zhang J., Okamura H. Expression of ubiquitin-related enzymes in the suprachiasmatic nucleus with special reference to ubiquitin carboxy-terminal hydrolase UchL1. Biomed. Res 2005, 26:43-44.
12. Factor S.A., Mcalarney T., Sanchezramos J.R., Weiner W.J. Sleep Disorders and Sleep Effect in Parkinsons-Disease. Mov. Disord 1990, 5:280-285.
13. Fronczek R., Overeem S., Lee S.Y.Y., Hegeman I.M., van Pelt J., van Duinen S.G., Lammers G.J., Swaab D.F. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007, 130:1577-1585.
14. Gong B., Cao Z., Zheng P., Vitolo O.V., Liu S., Staniszewski A., Moolman D., Zhang H., Shelanski M., Arancio O. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126:775-788.
15. Hattar S., Liao H.W., Takao M., Berson D.M., Yau K.W. Melanopsin-containing retinal. ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science 2002, 295:1065-1070.
16. Hobson D.E., Lang A.E., Martin W.R.W., Razmy A., Rivest J., Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group. J. Am. Med. Assoc 2002, 287:455-463.
17. Hope T., Keene J., Gedling K., Fairburn C.G., Jacoby R. Predictors of institutionalization for people with dementia living at home with a carer. Int. J. Geriatr. Psychiatry 1998, 13:682-690.
18. Kikuchi T., Mukoyama M., Yamazaki K., Moriya H. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse. Acta Neuropathol 1990, 80:145-151.
19. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395:451-452.
20. Lockley S.W., Evans E.E., Scheer F.A., Brainard G.C., Czeisler C.A., Aeschbach D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29:161-168.
21. Lupi D., Oster H., Thompson S., Foster R.G. The acute light-induction of sleep is mediated by OPN4-based photoreception. Nat. Neurosci 2008, 11:1068-1073.
22. Maraganore D.M., Farrer M.J., Hardy J.A., Lincoln S.J., McDonnell S.K., Rocca W.A. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999, 53:1858-1860.
23. Mrosovsky N., Hattar S. Impaired Masking Responses to Light in Melanopsin-Knockout Mice. Chronobiol. Int 2003, 20:989-999.
24. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
25. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet 2003, 12:1945-1958.
26. Paus S., Schmitz-Hubsch T., Wullner U., Vogel A., Klockgether T., Abele M. Bright light therapy in Parkinson's disease: a pilot study. Mov. Disord 2007, 22:1495-1498.
27. Rye D.B., Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002, 58:341-346.
28. Sakurai M., Sekiguchi M., Zushida K., Yamada K., Nagamine S., Kabuta T., Wada K. Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene. Eur. J. Neurosci 2008, 27:691-701.
29. Saper C.B., Cano G., Scammell T.E. Homeostatic, circadian, and emotional regulation of sleep. J. Comp. Neurol 2005, 493:92-98.
30. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1563.
31. Suh J.G., Oda K., Tanaka K., Yorifuji H., Tomita T., Wada K. Pathophysiological Study of Axonal Degeneration in the Gracile Axonal Dystrophy (Gad) Mutant Mouse. Biomed. Res 1994, 15:241-246.
32. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007, 130:1586-1595.
33. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Brain 2008, 131:e87.
34. Vitiello M.V., Borson S. Sleep disturbances in patients with Alzheimer's disease - Epidemiology, pathophysiology and treatment. CNS Drugs 2001, 15:777-796.
35. von Gall C., Duffield G.E., Hastings M.H., Kopp M.D., Dehghani F., Korf H.W., Stehle J.H. CREB in the mouse SCN: a molecular interface coding the phase-adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access. J. Neurosci 1998, 18:10389-10397.
36. von Gall C., Garabette M.L., Kell C.A., Frenzel S., Dehghani F., Schumm-Draeger P.M., Weaver D.R., Korf H.W., Hastings M.H., Stehle J.H. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat. Neurosci 2002, 5:234-238.
37. Willis G.L., Turner E.J. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int 2007, 24:521-537.
38. Xue S., Jia J. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Brain Res 2006, 1087:28-32.
39. Yamazaki K., Nakazawa T., Matsunaga M., Kumazawa A., Kaneko T., Wakabayashi T. Behavioral study on the gracile axonal dystrophy (GAD) mutant mouse. Jikken Dobutsu 1992, 41:523-527.
40. Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M., Ando K. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med 1988, 187:209-215.
41. Zhou J.N., Hofman M.A., Swaab D.F. Vip Neurons in the Human Scn in Relation to Sex, Age, and Alzheimers-Disease. Neurobiol. Aging 1995, 16:571-576.